Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immucell Cp (ICCC)

Immucell Cp (ICCC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,579
  • Shares Outstanding, K 7,213
  • Annual Sales, $ 13,720 K
  • Annual Income, $ -1,300 K
  • 60-Month Beta 1.15
  • Price/Sales 2.83
  • Price/Cash Flow 39.31
  • Price/Book 1.37
Trade ICCC with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +1,427,242.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.21 +0.19%
on 10/29/20
6.39 -18.31%
on 10/13/20
-0.26 (-4.74%)
since 09/29/20
3-Month
4.98 +4.82%
on 07/31/20
6.39 -18.31%
on 10/13/20
-0.59 (-10.15%)
since 07/29/20
52-Week
3.70 +41.08%
on 04/06/20
8.13 -35.79%
on 01/21/20
-0.08 (-1.51%)
since 10/29/19

Most Recent Stories

More News
ImmuCell Announces Preliminary, Unaudited Sales Results for the Quarter Ended September 30, 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 5.22 (+0.19%)
Global animal vaccine market is forecast to grow from an estimated $ 6.3 billion in 2019 to $ 8.1 billion by 2025

, /PRNewswire/ --  Read the full report: Global animal vaccine market is forecast to grow from an estimated in 2019 to by 2025. Rising meat consumption is a major factor driving the market. Another...

ICCC : 5.22 (+0.19%)
MRK : 76.25 (+0.09%)
NEOG : 69.57 (+1.80%)
VRBCF : 241.0000 (+4.78%)
ZTS : 161.92 (+2.04%)
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 5.22 (+0.19%)
Timing the Market, Is it Possible? - August 07, 2020

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

CLBS : 1.5300 (+0.66%)
ICCC : 5.22 (+0.19%)
HNGR : 17.99 (+1.41%)
VBIV : 2.53 (+5.42%)
KRMD : 5.83 (+3.00%)
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 5.22 (+0.19%)
ImmuCell Receives $500,000 Loan from the Maine Technology

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 5.22 (+0.19%)
Animal Vaccines Market to Exhibit 6.4% CAGR by 2027; Government-imposed Regulations on Timely Animal Vaccination to Aid in Expansion of Market says Fortune Business Insights(TM)

The global Animal Vaccines Market size is projected to hit USD 16.01 billion by the end of 2026 attributed to the increasing awareness about animal diseases and the increasing importance of animal health...

LLY : 132.68 (+1.04%)
ICCC : 5.22 (+0.19%)
MRK : 76.25 (+0.09%)
NEOG : 69.57 (+1.80%)
ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference

, /PRNewswire/ --  (NASDAQ: ICCC) a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...

ICCC : 5.22 (+0.19%)
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

ImmuCell Corporation (Nasdaq: ICCC) (the "Company" or "ImmuCell"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 5.22 (+0.19%)
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the...

ICCC : 5.22 (+0.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM,...

See More

Key Turning Points

2nd Resistance Point 5.38
1st Resistance Point 5.30
Last Price 5.22
1st Support Level 5.17
2nd Support Level 5.12

See More

52-Week High 8.13
Fibonacci 61.8% 6.44
Fibonacci 50% 5.91
Fibonacci 38.2% 5.39
Last Price 5.22
52-Week Low 3.70

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar